Skip to main content

CryoLife, Inc. (CRY)

NYSE: CRY · IEX Real-Time Price · USD
18.31 -0.53 (-2.81%)
Nov 26, 2021 1:00 PM EST - Market closed
Market Cap720.12M
Revenue (ttm)287.34M
Net Income (ttm)1.81M
Shares Out39.33M
EPS (ttm)0.04
PE Ratio435.95
Forward PE57.80
Dividendn/a
Ex-Dividend Daten/a
Volume224,220
Open19.64
Previous Close18.84
Day's Range17.60 - 18.60
52-Week Range18.74 - 32.34
Beta1.49
AnalystsStrong Buy
Price Target33.44 (+82.6%)
Earnings DateNov 4, 2021

About CRY

CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN...

IndustryHealth Care Equipment & Supplies
IPO DateFeb 11, 1993
CEOJames Mackin
Employees1,200
Stock ExchangeNYSE
Ticker SymbolCRY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for CryoLife stock is "Strong Buy." The 12-month stock price forecast is 33.44, which is an increase of 82.63% from the latest price.

Price Target
$33.44
(82.63% upside)
Analyst Consensus: Strong Buy

News

A Trio of Low Price-Sales Ratio Stocks

Value investors may find the following stocks to be attractive opportunities, as they have low price-sales ratios compared to the S&P 500 and good profitability.

Other symbols:AROCVSEC
1 week ago - GuruFocus

CryoLife to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics, and Digital Health & Services Forum

ATLANTA, Nov. 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that members of management will host one-on-on...

2 weeks ago - PRNewsWire

Wall Street Analysts Think CryoLife (CRY) Could Surge 51%: Read This Before Placing a Bet

The mean of analysts' price targets for CryoLife (CRY) points to a 50.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts i...

2 weeks ago - Zacks Investment Research

CryoLife (CRY) Tops Q3 Earnings Estimates

CryoLife (CRY) delivered earnings and revenue surprises of 420.00% and -0.95%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

3 weeks ago - Zacks Investment Research

Recap: Cryolife Q3 Earnings

Cryolife (NYSE:CRY) reported its Q3 earnings results on Thursday, November 4, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

3 weeks ago - Benzinga

CryoLife Reports Third Quarter 2021 Financial Results

ATLANTA, Nov. 4, 2021 /PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in the third quarter 2021 versus $65.1 million in the third quarter of 2020, ...

3 weeks ago - PRNewsWire

Earnings Preview: CryoLife (CRY) Q3 Earnings Expected to Decline

CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 weeks ago - Zacks Investment Research

CryoLife Announces Release Date and Teleconference Call Details for Third Quarter 2021 Financial Results

ATLANTA, Oct. 20, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2021 financial results wil...

1 month ago - PRNewsWire

Anthony Semedo Joins CryoLife Board of Directors

ATLANTA, Sept. 22, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today the appointment of Anthony "Tony" Semedo to ...

2 months ago - PRNewsWire

CryoLife to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

ATLANTA, Aug. 31, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Morg...

2 months ago - PRNewsWire

CryoLife to Participate in Upcoming Virtual Investor Conferences

ATLANTA, Aug. 2, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtu...

3 months ago - PRNewsWire

CryoLife (CRY) Reports Q2 Loss, Tops Revenue Estimates

CryoLife (CRY) delivered earnings and revenue surprises of -20.00% and 5.76%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Cryolife: Q2 Earnings Insights

Shares of Cryolife (NYSE:CRY) rose 2.9% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 700.00% year over year to $0.12, which beat the estimate ...

3 months ago - Benzinga

CryoLife Reports Second Quarter 2021 Financial Results

ATLANTA, July 29, 2021 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $76.1 million in the second quarter 2021 versus $53.8 million in the second quarter of 20...

3 months ago - PRNewsWire

CryoLife Announces Sale of PerClot to Baxter

ATLANTA, July 29, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has completed the sale of its PerClot...

Other symbols:BAX
3 months ago - PRNewsWire

Baxter Announces Acquisition of PerClot Polysaccharide Hemostatic System to Expand Advanced Surgery Portfolio

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of...

Other symbols:BAX
3 months ago - Business Wire

CryoLife (CRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CryoLife (CRY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results

ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2021 financial results wi...

4 months ago - PRNewsWire

CryoLife to Participate in the UBS Global Healthcare Virtual Conference

ATLANTA, May 18, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming UBS G...

6 months ago - PRNewsWire

CryoLife (CRY) Soars 24.2%: Is Further Upside Left in the Stock?

CryoLife (CRY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

6 months ago - Zacks Investment Research

CryoLife (CRY) Reports Q1 Loss, Tops Revenue Estimates

CryoLife (CRY) delivered earnings and revenue surprises of 27.27% and 15.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

6 months ago - Zacks Investment Research

Cryolife: Q1 Earnings Insights

Shares of Cryolife (NYSE:CRY) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 137.50% year over year to $0.03, which beat the estimate ...

6 months ago - Benzinga

CryoLife Reports First Quarter 2021 Financial Results

ATLANTA, April 29, 2021 /PRNewswire/ -- First Quarter and Recent Business Highlights: Achieved total revenues of $71.1 million in the first quarter 2021 versus $66.4 million in the first quarter of 2020...

6 months ago - PRNewsWire

Earnings Preview: CryoLife (CRY) Q1 Earnings Expected to Decline

CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2021 Financial Results

ATLANTA, April 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2021 financial results wi...

7 months ago - PRNewsWire